SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-210688
Filing Date
2023-08-11
Accepted
2023-08-11 16:02:58
Documents
12
Period of Report
2023-08-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d539576d8k.htm   iXBRL 8-K 27599
  Complete submission text file 0001193125-23-210688.txt   149716

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rapt-20230811.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rapt-20230811_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rapt-20230811_pre.xml EX-101.PRE 11253
6 EXTRACTED XBRL INSTANCE DOCUMENT d539576d8k_htm.xml XML 3355
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 231163933
SIC: 2834 Pharmaceutical Preparations